Brommapojkarna

🧠 GAIS enter as clear market favourites and arrive with stronger recent momentum, though significant data gaps limit analytical conviction.

🧠 Sirius profile as the stronger, more clinical side and the Poisson model firmly supports an away-win lean, though data gaps limit conviction.